wells fargo dsip 2019 witnesses a 23% fall in net income in Q3 Quarterly Performance - Diversified Stock
Description
Reducing the risk of metabolic diseases: Inhibiting NNMT may counteract the adverse metabolic changes associated with obesity, such as fatty liver disease
Bulletin of Experimental Biology and Medicine, 131(3), 285292
At worst, it could produce unintended and adverse effects
